story of the week
Clinical and Molecular Characteristics of HER2–Low-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical and Molecular Characteristics of HER2-Low-Positive Breast Cancer: Pooled Analysis of Individual Patient Data From Four Prospective, Neoadjuvant Clinical Trials
Lancet Oncol 2021 Jul 09;[EPub Ahead of Print], C Denkert, F Seither, A Schneeweiss, T Link, JU Blohmer, M Just, P Wimberger, A Forberger, H Tesch, C Jackisch, S Schmatloch, M Reinisch, EF Solomayer, WD Schmitt, C Hanusch, PA Fasching, K Lübbe, C Solbach, J Huober, K Rhiem, F Marmé, T Reimer, M Schmidt, BV Sinn, W Janni, E Stickeler, L Michel, O Stötzer, E Hahnen, J Furlanetto, S Seiler, V Nekljudova, M Untch, S LoiblFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.